The U.S. cardiovascular device market was $8.29 billion in 2007 and is expected to reach $20.70 billion by 2014, which represents a Compound Annual Growth Rate (CAGR) of 14.5% from 2009 to 2014. The U.S. cardiovascular biomaterial market was $3.43 billion in 2007 and is expected to reach $7.74 billion in 2014 with a CAGR of 13% from 2009 to 2014.1
US BioDesign is well situated to take full advantage of these rapidly growing markets as a result of the world class research and development expertise of its team and its ability to solve customers problems as biomedical engineers, not textile engineers. US BioDesigns focus on the right medical construct solution for its customers problems has resulted in a significant decrease in its delivery timelines, which in turn has allowed customers to utilize US BioDesigns components into their devices, quickly and efficiently, thus shortening the overall development timelines.
"Time is money for our customers," says US BioDesign CEO, Tom Molz. "US BioDesigns mission is to be the most effective OEM supplier of biomedical textile structures in the industry and I am very pleased that we are having quite a bit of initial success, especially in the cardiovascular area," he added.
About US BioDesign
US BioDesign is a global leader in biomedical textile structure components for medical devices. US BioDesign delivers the right solution to solve customer problems with unmatched timeliness and efficiency as a result of its biomedical engineering expertise and an unparalleled understanding of medical construct development involving polymeric and/or metallic raw materials. US BioDesign serves the cardiovascular, orthopedic, general surgery and neurological device segment of the health care industry.
1 Biomaterials – Industry Experts, "A Global Market Overview, April, 2011"
Posted by Sean Fenske, Editor-in-Chief, MDT